Advertisement

Wake-up call for more doctor–patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer

  • Christian Gilfrich
  • Odilo Maurer
  • Philipp J. Spachmann
  • Mirja K. Dombrowski
  • Maximilian Burger
  • Matthias May
Letter to the Editor
  • 24 Downloads

Dear Editor,

It was with great interest that we read the recently published data in the World Journal of Urology from the renowned Melbourne working group headed by Nathan Lawrentschuk [1]. In this study, a survey was presented with 10 descriptive and 24 explorative items for the assessment of patients’ knowledge about the risk factor of smoking in general and in particular regarding urological aspects. Between November 2015 and March 2016, a total of 134 patients with either benign or malignant urological diseases took part in this survey; 112 of them could then be included in the final data analysis. As a result of the study, the Australian colleagues reported that smoking was named by 95% of patients as a risk factor for lung cancer, but only 46% identified smoking as a risk factor for urothelial carcinoma of the bladder (UCB) [1]. It is justified to ask: what is going wrong in the UCB information campaigns and in the targeted doctor–patient communication on this subject, which is...

Notes

Author contribution statement

MM, CG, and MB: protocol/project development; PJS, OM, and MKD: data collection or management; MM and MKD: data analysis; and CG, PJS, OM, MKD, MB, and MM: manuscript writing/editing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

The study was in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Informed consent was affirmed from all individual participants included in the study and ethical committee approval was obtained (BLAEK-EC No. 13012).

References

  1. 1.
    Khan M, Papa N, Manning T, Nzenza T, Simionato L, Lawrentschuk N (2018) Knowledge of smoking as a risk factor for disease among urology clinic patients in Australia. World J Urol 27:1–6Google Scholar
  2. 2.
    May M, Maurer O, Lebentrau S, Brookman-May S (2017) Lower use of prostate specific antigen testing by cigarette smokers-another possible explanation for the unfavorable prostate cancer (PCA) specific prognosis in smokers? Cancer Epidemiol 46:34–35CrossRefPubMedGoogle Scholar
  3. 3.
    May M, Fritsche HM, Gilfrich C et al (2018) What do patients with urothelial cancer know about the association of their tumor disease with smoking habits? Results of a German survey study. Investig Clin Urol 59(2):91–97CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    May M, Gilfrich C, Spachmann P et al (2016) What do prostate cancer patients know about smoking? Results of a bicentric questionnaire study (KRAUT study). Urologe A 55(8):1078–1085CrossRefPubMedGoogle Scholar
  5. 5.
    Dombrowski MK, May M, Spachmann P et al (2018) Influence of gender and age on willingness to reduce nicotine consumption—results of a survey in urological cancer patients (KRAUT study). Clin Genitourin Cancer (Accepted)Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of UrologySt. Elisabeth Hospital StraubingStraubingGermany
  2. 2.Department of Urology, Caritas St. Josef Medical CenterUniversity of RegensburgRegensburgGermany

Personalised recommendations